Recent Issues in Varicella-Zoster Virus Latency.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
07 10 2021
Historique:
received: 06 08 2021
revised: 30 09 2021
accepted: 02 10 2021
entrez: 26 10 2021
pubmed: 27 10 2021
medline: 8 2 2022
Statut: epublish

Résumé

Varicella-zoster virus (VZV) is a human herpes virus which causes varicella (chicken pox) as a primary infection, and, following a variable period of latency in neurons in the peripheral ganglia, may reactivate to cause herpes zoster (shingles) as well as a variety of neurological syndromes. In this overview we consider some recent issues in alphaherpesvirus latency with special focus on VZV ganglionic latency. A key question is the nature and extent of viral gene transcription during viral latency. While it is known that this is highly restricted, it is only recently that the very high degree of that restriction has been clarified, with both VZV gene 63-encoded transcripts and discovery of a novel VZV transcript (VLT) that maps antisense to the viral transactivator gene 61. It has also emerged in recent years that there is significant epigenetic regulation of VZV gene transcription, and the mechanisms underlying this are complex and being unraveled. The last few years has also seen an increased interest in the immunological aspects of VZV latency and reactivation, in particular from the perspective of inborn errors of host immunity that predispose to different VZV reactivation syndromes.

Identifiants

pubmed: 34696448
pii: v13102018
doi: 10.3390/v13102018
pmc: PMC8540691
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

J Infect Dis. 2021 May 28;223(10):1776-1786
pubmed: 32946550
J Virol. 2015 Sep;89(18):9288-98
pubmed: 26136570
J Virol. 2008 Sep;82(17):8629-46
pubmed: 18579611
J Virol. 2012 Sep;86(18):9558-65
pubmed: 22761371
Infect Genet Evol. 2010 Jan;10(1):14-25
pubmed: 19772930
PLoS Pathog. 2013;9(8):e1003512
pubmed: 23935496
Viruses. 2018 Jun 28;10(7):
pubmed: 29958408
Viruses. 2019 May 31;11(6):
pubmed: 31159224
J Virol. 2006 May;80(10):4921-6
pubmed: 16641283
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16055-9
pubmed: 16247011
J Vis Exp. 2012 Apr 02;(62):
pubmed: 22491318
Proc Natl Acad Sci U S A. 1982 Apr;79(7):2207-10
pubmed: 6285373
Blood. 2012 Apr 12;119(15):3450-7
pubmed: 22294732
J Virol. 2006 Mar;80(5):2358-68
pubmed: 16474142
Trends Mol Med. 2018 Oct;24(10):904-915
pubmed: 30115567
Cell. 2009 Jun 26;137(7):1194-211
pubmed: 19563753
J Virol. 2011 Jul;85(13):6678-86
pubmed: 21525352
J Virol. 2007 May;81(10):5192-201
pubmed: 17267480
Antiviral Res. 2021 Aug;192:105103
pubmed: 34082058
Cell Host Microbe. 2015 Dec 9;18(6):639-41
pubmed: 26651937
J Neuroimmunol. 2017 Jul 15;308:65-101
pubmed: 28363461
Trends Biochem Sci. 2003 Jun;28(6):294-304
pubmed: 12826401
Lancet. 1981 Nov 28;2(8257):1227-8
pubmed: 6171694
Future Virol. 2011 Mar;6(3):341-355
pubmed: 21695042
J Virol. 2004 Sep;78(18):10178-86
pubmed: 15331750
Ann Neurol. 2003 Nov;54(5):678-82
pubmed: 14595659
Science. 2001 Aug 10;293(5532):1074-80
pubmed: 11498575
J Infect Dis. 1973 Apr;127(4):415-23
pubmed: 4571702
J Virol. 2003 Jun;77(12):6660-5
pubmed: 12767985
Viruses. 2021 Mar 15;13(3):
pubmed: 33804210
PLoS Pathog. 2012 Feb;8(2):e1002540
pubmed: 22383875
J Virol. 2002 May;76(10):4764-72
pubmed: 11967293
Viruses. 2019 Jan 26;11(2):
pubmed: 30691086
J Virol. 2020 Jan 17;94(3):
pubmed: 31694955
J Virol. 2011 Sep;85(18):9414-24
pubmed: 21752906
J Virol. 1995 Aug;69(8):4994-5010
pubmed: 7609070
J Virol. 2012 Dec;86(23):12741-59
pubmed: 22973047
Nucleic Acids Res. 2013 Jan;41(Database issue):D188-94
pubmed: 23193294
J Virol. 2000 Dec;74(24):11893-8
pubmed: 11090189
J Transl Med. 2015 Oct 20;13:333
pubmed: 26482341
J Virol. 2009 Oct;83(20):10677-83
pubmed: 19656888
J Virol. 2019 Jun 14;93(13):
pubmed: 30996085
Clin Infect Dis. 2020 Aug 28;:
pubmed: 32856043
N Engl J Med. 1989 Jun 29;320(26):1731-5
pubmed: 2543925
Viruses. 2018 Nov 02;10(11):
pubmed: 30400213
Clin Infect Dis. 2006 Nov 1;43(9):1194-7
pubmed: 17029141
Virology. 2004 Jul 1;324(2):340-9
pubmed: 15207620
Sci Immunol. 2020 Dec 11;5(54):
pubmed: 33310865
Rev Med Virol. 2011 May;21(3):154-80
pubmed: 21538665
Genes Immun. 2019 Mar;20(3):214-223
pubmed: 29728610
J Virol. 2007 Mar;81(6):2950-6
pubmed: 17192313
J Neurovirol. 2002 Dec;8 Suppl 2:75-9
pubmed: 12491155
Neurol Neuroimmunol Neuroinflamm. 2018 Sep 07;5(6):e500
pubmed: 30211253
Gene. 1999 Oct 18;239(1):1-14
pubmed: 10571029
J Neuropathol Exp Neurol. 2006 Oct;65(10):1022-30
pubmed: 17021407
Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):10835-40
pubmed: 17578910
Ann Intern Med. 1994 Sep 1;121(5):334-8
pubmed: 8042822
PLoS Pathog. 2015 Jun 04;11(6):e1004885
pubmed: 26042814
J Virol. 1994 Dec;68(12):7900-8
pubmed: 7966580
FEBS Lett. 2009 Oct 20;583(20):3335-8
pubmed: 19786025
Nat Rev Dis Primers. 2015 Jul 02;1:15016
pubmed: 27188665
J Gen Virol. 1987 Jun;68 ( Pt 6):1761-5
pubmed: 3035069
N Engl J Med. 1974 Jan 31;290(5):243-5
pubmed: 4358055
J Neurovirol. 2020 Oct;26(5):696-703
pubmed: 32696182
Cleve Clin J Med. 2007 Jul;74(7):489-94, 496, 498-9 passim
pubmed: 17682626
J Virol. 2010 Feb;84(4):1920-33
pubmed: 20007274
J Virol. 2011 Mar;85(5):2276-87
pubmed: 21177814
Antiviral Res. 2005 Nov;68(2):56-65
pubmed: 16118026
Nat Commun. 2020 Dec 10;11(1):6324
pubmed: 33303747
Brain. 1992 Apr;115 ( Pt 2):383-98
pubmed: 1318768
Mol Biol Cell. 2014 Mar;25(6):904-15
pubmed: 24430871
Virology. 2018 Sep;522:220-227
pubmed: 30053655
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4658-62
pubmed: 9539794
mBio. 2018 Feb 6;9(1):
pubmed: 29437926
Eur J Case Rep Intern Med. 2020 Aug 21;7(12):001746
pubmed: 33312993
J Virol. 2018 Mar 28;92(8):
pubmed: 29437965
PLoS Pathog. 2019 Nov 14;15(11):e1008076
pubmed: 31725813
Neurology. 2011 Feb 1;76(5):416-7
pubmed: 21282588
Pediatrics. 1972 Nov;50(5):718-22
pubmed: 5084186
J Virol. 1998 Sep;72(9):7137-43
pubmed: 9696807
J Virol. 2005 Nov;79(22):14079-87
pubmed: 16254342
J Infect Dis. 2021 May 11;:
pubmed: 33974706
J Virol. 1996 May;70(5):2789-96
pubmed: 8627753
J Virol. 2008 Mar;82(6):2821-35
pubmed: 18184710
mBio. 2017 Aug 15;8(4):
pubmed: 28811345
J Gen Virol. 2015 Jul;96(Pt 7):1581-602
pubmed: 25794504
J Neurovirol. 2003 Apr;9(2):194-204
pubmed: 12707850
Nucleic Acids Res. 2019 Jul 2;47(W1):W636-W641
pubmed: 30976793
Biochem J. 2021 Feb 12;478(3):511-532
pubmed: 33567070
Cell Host Microbe. 2015 Dec 9;18(6):649-58
pubmed: 26651941
mBio. 2020 Oct 6;11(5):
pubmed: 33024035
Proc Natl Acad Sci U S A. 2015 Jan 6;112(1):256-61
pubmed: 25535384
Genes Dev. 2016 Apr 15;30(8):881-91
pubmed: 27083996
Genes Dev. 2002 Feb 1;16(3):271-88
pubmed: 11825869
J Virol. 2003 Mar;77(6):3516-30
pubmed: 12610127
J Virol. 2020 Jul 30;94(16):
pubmed: 32493818
Nucleic Acids Res. 2008 Jan;36(Database issue):D83-7
pubmed: 17981843
J Virol. 2018 May 14;92(11):
pubmed: 29514910
N Engl J Med. 1969 May 29;280(22):1191-4
pubmed: 4181206
Am J Epidemiol. 1970 Apr;91(4):430-8
pubmed: 4316199
Genes Dev. 2009 Apr 1;23(7):781-3
pubmed: 19339683
Curr Opin Immunol. 2020 Feb;62:106-122
pubmed: 32014647
Curr Issues Mol Biol. 2021;42:41-80
pubmed: 33159012
Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18820-4
pubmed: 22065742
Methods. 2015 Nov 15;90:76-84
pubmed: 25986169
Cell. 1990 Aug 10;62(3):503-14
pubmed: 1974172
J Infect. 2015 Jun;71 Suppl 1:S47-53
pubmed: 25917799
Front Microbiol. 2019 Sep 11;10:2117
pubmed: 31572325
BMC Bioinformatics. 2006 Oct 12;7:446
pubmed: 17038168
Nat Immunol. 2009 Oct;10(10):1065-72
pubmed: 19609254
J Virol. 2004 Feb;78(3):1139-49
pubmed: 14722269
J Clin Invest. 2017 Sep 1;127(9):3543-3556
pubmed: 28783042
Viruses. 2021 Jun 02;13(6):
pubmed: 34199543
Neurotherapeutics. 2016 Jul;13(3):509-13
pubmed: 27032406
J Virol. 2007 Aug;81(15):8149-56
pubmed: 17507490
Clin Neurol Neurosurg. 2012 Sep;114(7):1086-7
pubmed: 22402203
Nucleic Acids Res. 1983 Nov 11;11(21):7409-25
pubmed: 6647026
J Virol. 2020 Sep 15;94(19):
pubmed: 32699090
Cell. 1983 Dec;35(2 Pt 1):433-40
pubmed: 6317188
J Virol. 2020 Jan 31;94(4):
pubmed: 31776275
BMC Biotechnol. 2016 Aug 31;16(1):64
pubmed: 27580861
J Virol. 2018 Oct 12;92(21):
pubmed: 30089701
J Virol. 1999 Oct;73(10):8571-7
pubmed: 10482610
J Virol. 2017 Dec 14;92(1):
pubmed: 29046461
Nat Commun. 2018 Mar 21;9(1):1167
pubmed: 29563516
J Neurovirol. 2012 Dec;18(6):456-61
pubmed: 22851387
J Am Chem Soc. 2013 Jul 31;135(30):11216-21
pubmed: 23829592
Trends Microbiol. 2012 Dec;20(12):604-11
pubmed: 22963857
J Virol. 2006 Feb;80(4):2063-8
pubmed: 16439563

Auteurs

Peter G E Kennedy (PGE)

Institute of Neuroscience and Psychology, University of Glasgow, Glasgow G61 1QH, UK.

Trine H Mogensen (TH)

Department of Infectious Diseases, Aarhus University Hospital, 8000 Aarhus, Denmark.
Department of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.

Randall J Cohrs (RJ)

Department of Neurology, University of Colorado School of Medicine, 80045 Aurora, CO, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH